Zobrazeno 1 - 10
of 10 457
pro vyhledávání: '"Giobbie-Hurder A"'
Autor:
Karam Khaddour, Mofei Liu, Emily Y. Kim, Furkan Bahar, Matheus M. Lôbo, Anita Giobbie-Hurder, Ann W. Silk, Manisha Thakuria
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionMerkel cell carcinoma (MCC) is a rare and aggressive neuroendocrine malignancy of the skin with a predilection for metastases. This study investigates the clinical outcomes in patients presenting with de novo Stage IV MCC according to the
Externí odkaz:
https://doaj.org/article/488d2e9a2be547589619e202d1ab3b73
Autor:
David Liu, F Stephen Hodi, Rizwan Haq, Anita Giobbie-Hurder, Ann W Silk, Patrick A Ott, Tamara A Sussman, Elizabeth I Buchbinder, Anna K Maloney, Nikita Katukota, Miklos C Fogarasi, Megan Insco
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 8 (2024)
Background The combination of ipilimumab and nivolumab is a highly effective treatment for metastatic cutaneous melanoma. However, immune-related adverse events (irAEs) are common, often necessitating treatment interruption and the use of immunosuppr
Externí odkaz:
https://doaj.org/article/4034db27552e463dbba1b096428e2377
Autor:
Tamara A. Sussman, Mariano Severgnini, Anita Giobbie-Hurder, Philip Friedlander, Scott J. Swanson, Michael Jaklitsch, Thomas Clancy, Laura A. Goguen, David Lautz, Richard Swanson, Heather Daley, Jerome Ritz, Glenn Dranoff, F. Stephen Hodi
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundIn the era of immune checkpoint blockade, the role of cancer vaccines in immune priming has provided additional potential for therapeutic improvements. Prior studies have demonstrated delayed type hypersensitivity and anti-tumor immunity wi
Externí odkaz:
https://doaj.org/article/ba235126d5b84090b4b832fedad15dec
Autor:
Smart, Alicia C., Giobbie-Hurder, Anita, Desai, Vineet, Xing, Jessica L., Lukens, John N., Taunk, Neil K., Sullivan, Ryan J., Mooradian, Meghan J., Hsu, Charles C., Buchbinder, Elizabeth I., Schoenfeld, Jonathan D.
Publikováno v:
In Advances in Radiation Oncology January 2024 9(1)
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Khaddour, Karam, Mofei Liu, Kim, Emily Y., Bahar, Furkan, Lôbo, Matheus M., Giobbie-Hurder, Anita, Silk, Ann W., Thakuria, Manisha
Publikováno v:
Frontiers in Oncology; 2024, p1-7, 7p
Autor:
Sara M Tolaney, James Lindsay, Michael Manos, Biagio Ricciuti, Anita Giobbie-Hurder, Scott J Rodig, Joao V Alessi, Mark M Awad, Sandro Santagata, Bruce E Johnson, Glenn J Hanna, Elio Adib, Jason Weirather, Xinan Wang, Bijaya Sharma, Kathleen Pfaff, Kristen D Felt, William Lotter, Panagiotis Konstantinopoulos, Madison Turner, Federica Pecci, Emma L Welsh, Stephanie M Jones, Jennifer O Altreuter, Ian D Dryg, Alessandro Di Federico, Malini M Gandhi, Sabrina J Chan, Marta Holovatska, Melissa E Hughes, O’Meara Tess A, Neal I Lindeman, Jennifer Curtis, Peter K Sorger, Ethan Cerami, Lynette M Sholl, Jonathan A Novak
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/02ccda4c59ce49c1ba7f9100a145659a
Autor:
Wright, Kyle T., Weirather, Jason L., Jiang, Sizun, Kao, Katrina Z., Sigal, Yari, Giobbie-Hurder, Anita, Shipp, Margaret A., Rodig, Scott J.
Publikováno v:
In Blood Advances 22 August 2023 7(16):4633-4646
Autor:
Foluso O. Ademuyiwa, Feng Gao, Cherease R. Street, Ina Chen, Donald W. Northfelt, Robert Wesolowski, Mili Arora, Adam Brufsky, E. Claire Dees, Cesar A. Santa-Maria, Roisin M. Connolly, Jeremy Force, Alvaro Moreno-Aspitia, John M. Herndon, Madelyn Carmody, Sherri R. Davies, Sarah Larson, Kathleen L. Pfaff, Stephanie M. Jones, Jason L. Weirather, Anita Giobbie-Hurder, Scott J. Rodig, Zheng Liu, Ian S. Hagemann, Elad Sharon, William E. Gillanders
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-11 (2022)
Abstract Atezolizumab with chemotherapy has shown improved progression-free and overall survival in patients with metastatic PD-L1 positive triple negative breast cancer (TNBC). Atezolizumab with anthracycline- and taxane-based neoadjuvant chemothera
Externí odkaz:
https://doaj.org/article/d2b06f8f41a040519a09fe040f35b01e